These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37682525)

  • 1. Workforce affiliation in primary and secondary prevention implantable cardioverter defibrillator patients: a nationwide Danish study.
    Rosenkranz SH; Wichmand CH; Smedegaard L; Møller S; Bjerre J; Schou M; Torp-Pedersen C; Philbert BT; Larroudé C; Melchior TM; Nielsen JC; Johansen JB; Riahi S; Holmberg T; Gislason G; Ruwald AC
    Eur Heart J Qual Care Clin Outcomes; 2024 Jun; 10(4):314-325. PubMed ID: 37682525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome in patients with implantable cardioverter-defibrillator and cancer: a nationwide study.
    Christensen AM; Bjerre J; Schou M; Jons C; Vinther M; Gislason GH; Johansen JB; Nielsen JC; Petersen HH; Riahi S; Ruwald AC
    Europace; 2019 Mar; 21(3):465-474. PubMed ID: 30535192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Employment Status and Sick Leave After First-Time Implantable Cardioverter Defibrillator Implantation: Results From the COPE-ICD Trial.
    Christensen AV; Øhlers AA; Zwisler AD; Svendsen JH; Berg SK
    J Cardiovasc Nurs; 2017; 32(5):448-454. PubMed ID: 27631118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
    Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter defibrillator and survival after out-of-hospital cardiac arrest due to acute myocardial infarction in Denmark in the years 2001-2012, a nationwide study.
    Winther-Jensen M; Kjaergaard J; Lassen JF; Køber L; Torp-Pedersen C; Hansen SM; Lippert F; Kragholm K; Christensen EF; Hassager C
    Eur Heart J Acute Cardiovasc Care; 2017 Mar; 6(2):144-154. PubMed ID: 28058848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes in African Americans undergoing cardioverter-defibrillator implantation for primary prevention of sudden cardiac death: findings from the Prospective Observational Study of Implantable Cardioverter-Defibrillators (PROSE-ICD).
    Zhang Y; Kennedy R; Blasco-Colmenares E; Butcher B; Norgard S; Eldadah Z; Dickfeld T; Ellenbogen KA; Marine JE; Guallar E; Tomaselli GF; Cheng A
    Heart Rhythm; 2014 Aug; 11(8):1377-83. PubMed ID: 24793459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of co-morbidity burden on appropriate implantable cardioverter defibrillator therapy and all-cause mortality: insight from Danish nationwide clinical registers.
    Ruwald AC; Vinther M; Gislason GH; Johansen JB; Nielsen JC; Petersen HH; Riahi S; Jons C
    Eur J Heart Fail; 2017 Mar; 19(3):377-386. PubMed ID: 27905161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy-Are there predictors of appropriate therapy?
    Weissler-Snir A; Dorian P; Rakowski H; Care M; Spears D
    Heart Rhythm; 2021 Jan; 18(1):63-70. PubMed ID: 32800967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of beta-blocker dose in prevention of ventricular tachyarrhythmias, heart failure hospitalizations, and death in primary prevention implantable cardioverter-defibrillator recipients: a Danish nationwide cohort study.
    Ruwald AC; Gislason GH; Vinther M; Johansen JB; Nielsen JC; Philbert BT; Torp-Pedersen C; Riahi S; Jøns C
    Europace; 2018 Sep; 20(FI2):f217-f224. PubMed ID: 29684191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: a 2012 calculation for a midwestern health referral region.
    Hoang A; Shen C; Zheng J; Taylor S; Groh WJ; Rosenman M; Buxton AE; Chen PS
    Heart Rhythm; 2014 May; 11(5):849-55. PubMed ID: 24566233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of Implantable Cardioverter Defibrillator Therapy and Mortality in Primary and Secondary Prevention of Sudden Cardiac Death.
    Konstantino Y; Shafat T; Novack V; Novack L; Amit G
    Isr Med Assoc J; 2015 Dec; 17(12):760-3. PubMed ID: 26897978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to reassess ejection fraction after acute myocardial infarction in potential implantable cardioverter/defibrillator candidates: insights from the Translational Research Investigating Underlying disparities in acute Myocardial infarction Patients' Health Status (TRIUMPH) registry.
    Miller AL; Gosch K; Daugherty SL; Rathore S; Peterson PN; Peterson ED; Ho PM; Chan PS; Lanfear DE; Spertus JA; Wang TY
    Am Heart J; 2013 Oct; 166(4):737-43. PubMed ID: 24093855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
    Herman D; Stros P; Curila K; Kebza V; Osmancik P
    Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of appropriate implantable cardioverter-defibrillator therapy and mortality after implantable cardioverter-defibrillator generator replacement: results from a real-world nationwide cohort.
    Ruwald MH; Ruwald AC; Johansen JB; Gislason G; Nielsen JC; Philbert B; Riahi S; Vinther M; Lindhardt TB
    Europace; 2019 Aug; 21(8):1211-1219. PubMed ID: 31329849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD).
    Cheng A; Zhang Y; Blasco-Colmenares E; Dalal D; Butcher B; Norgard S; Eldadah Z; Ellenbogen KA; Dickfeld T; Spragg DD; Marine JE; Guallar E; Tomaselli GF
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1084-91. PubMed ID: 25273351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thirteen-year nationwide trends in use of implantable cardioverter-defibrillators and subsequent long-term survival.
    Schmidt M; Pedersen SB; Farkas DK; Hjortshøj SP; Bøtker HE; Nielsen JC; Sørensen HT
    Heart Rhythm; 2015 Sep; 12(9):2018-27. PubMed ID: 25937527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Italian Implantable Cardioverter-Defibrillator Registry. A survey of the national activity during the years 2001-2003.
    Proclemer A; Ghidina M; Cicuttini G; Gregori D; Fioretti PM
    Ital Heart J; 2005 Mar; 6(3):272-80. PubMed ID: 15875520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defibrillator implantations for primary prevention in the United States: Inappropriate care or inadequate documentation: Insights from the National Cardiovascular Data ICD Registry.
    Kaiser DW; Tsai V; Heidenreich PA; Goldstein MK; Wang Y; Curtis J; Turakhia MP;
    Heart Rhythm; 2015 Oct; 12(10):2086-93. PubMed ID: 25982720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.